Form 4: UNH Director Acquires 261 Deferred Stock Units

UnitedHealth Group Director John H. Noseworthy acquired 261 deferred stock units as part of his regular quarterly compensation, increasing his beneficial ownership to 6,693 units.

Summary

• John H. Noseworthy, a Director of UnitedHealth Group Inc. (UNH), acquired 261 shares of common stock in the form of deferred stock units.
• The transaction occurred on October 1, 2025, and was reported on October 3, 2025.
• These deferred stock units were granted as regular quarterly compensation for his service as a director.
• The units are immediately vested but must be retained until the director completes service on the Board.
• Following this transaction, Mr. Noseworthy beneficially owns 6,693 deferred stock units.
• The acquisition price for these units was $0, as they represent compensation.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates a director's continued commitment and alignment of interests through equity compensation, which is a routine and expected event.

Positives

• Director John H. Noseworthy increased his beneficial ownership in UnitedHealth Group, aligning his interests further with shareholders.
• The acquisition represents regular quarterly compensation, indicating standard corporate governance practices for director remuneration.

Negatives

• No negative aspects are indicated in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This transaction is a routine insider filing, common across publicly traded companies, where directors receive equity-based compensation to align their long-term interests with those of shareholders. Such compensation structures are standard practice in the healthcare industry and broader corporate landscape.

Comparison to Industry Standards

• The practice of compensating directors with deferred stock units is a common corporate governance standard across major U.S. corporations, including peers in the healthcare sector like CVS Health (CVS) or Elevance Health (ELV).
• The immediate vesting with a retention requirement until service completion is a typical structure designed to ensure long-term commitment and alignment.

Corporate Governance

Related Party Transactions

• The acquisition of deferred stock units by Director John H. Noseworthy represents compensation from the issuer, which is a standard related-party transaction for director remuneration.

Stakeholder Impact

• Shareholders: Positive impact due to increased alignment of a director's financial interests with the company's long-term performance.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Keywords

UnitedHealth Group, UNH, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, John H. Noseworthy, Beneficial Ownership